Specifically, in gastric cancer, elevated serum chemerin levels are significantly higher compared to healthy controls and also correlate with advanced clinical stages, non-intestinal types of gastric cancer, and increased cellular invasiveness. This evidence concerns the gene RARRES2 and gastric cancer.